A phase II randomized trial of RAdium-223 dichloride and SABR versus SABR for oligomEtastatic prostate caNcerS (RAVENS).
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Matthew Pierre Deek, Hamza Hasan, Ryan Phillips, Robert F Hobbs, Ana Ponce Kiess, Hao Wang, Elizabeth D Thompson, Jonathan Powell, Curtiland Deville, Stephen C. Greco, Danny Song, Steven P. Rowe, Samuel R. Denmeade, Mark Christopher Markowski, Emmanuel S. Antonarakis, Michael Anthony Carducci, Mario A. Eisenberger, Kenneth J. Pienta, Channing Judith Paller, Phuoc T. Tran
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3028720518